China-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapy Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4970120_CN70120_0